From: Prescription of cardioprotective drugs after acute kidney injury
 |  | Patients on cardioprotective drugs pre admission | ||||
---|---|---|---|---|---|---|
CKD stage at hospital discharge as per eGFR | Number of patients with severe AKI who survived to hospital discharge | Number of patients | Mean baseline eGFR pre-hospitalisation (when available) | Mean eGFR at hospital discharge | Number of patients in whom cardioprotective drugs were discontinued and not restarted after hospital discharge | Appropriate documentation in hospital discharge letter regarding AKI and drug discontinuation (% of relevant patients) |
V | 3 (2.3%) | 2 | >60 (2 pts) | 12 | 2 (100%) | 2 (100%) |
IV | 18 (13.8%) | 14 | 38.9 (9 pts) | 24.1 | 9 (64%) | 5 (55.5%) |
IIIb | 28 (21.5%) | 25 | 59.4 (21 pts) | 39 | 17 (68%) | 12 (71%) |
IIIa | 24 (18%) | 15 | 44.1 (7 pts) | 52.4 | 8 (53%) | 3 (38%) |
I or II | 58 (44.6%) | 32 | >60 (22 pts) | >60 | 17 (53%) | 8 (47%) |
Total | 130 | 88 | 61 pts | 88 pts | 53 (60.2%) | 30 (56.6%) |